Purpose of the Test
- Determine if the tumor expresses high levels of the HER2 protein.
- Confirm HER2 gene amplification in borderline cases using FISH technology.
- Assist oncologists in selecting appropriate targeted therapies like Trastuzumab.
Book HER2/neu Test in Saudi Arabia | Lahalak Medical Platform
HER2 testing is a critical step in determining targeted therapy plans for breast and gastric cancers, helping evaluate tumor response to specialized medications to ensure the best possible clinical outcomes.
Scientific name: HER2/neu Testing by IHC and FISH
An advanced laboratory procedure evaluating HER2 protein expression or gene amplification in tissue samples using IHC and FISH techniques to determine eligibility for targeted and immune therapies.
Service type
Histopathology Laboratory Test
Duration
3-5 business days
Fasting
Fasting is not required
Included Services
- Immunohistochemistry (IHC) analysis
- Fluorescence In Situ Hybridization (FISH) analysis
- Pathologist consultation report
Medical Service Information
Target Groups
- Patients newly diagnosed with invasive breast cancer.
- Patients with advanced gastric or gastroesophageal junction cancer.
- Recurrent cancer cases to re-evaluate treatment options.
Clinical Significance
- Identifies candidates for anti-HER2 targeted biological therapies.
- Helps avoid unnecessary conventional chemotherapy side effects.
- Improves survival rates through personalized precision medicine.
Conditions & Notices
- Requires a preserved tissue sample (biopsy block)
- Provide previous medical reports related to the tumor
Medical services you might also like
